Estimating the cost-effectiveness of treatment for prevention of thromboembolic events in at-risk adults with non-valvular atrial fibrillation. (2018). Farmeconomia. Health Economics and Therapeutic Pathways, 19(1). https://doi.org/10.7175/fe.v19i1.1346